Lung (includes NSCLC, SCLC, Mesothelioma)
Featured Articles
(BMS) Aug 17, 2018 - Bristol-Myers Squibb Company today announced that Opdivo (nivolumab) received approval from the U.S. Food and Drug Administration (FDA) as the first and only Immuno-Oncology treatment option for patients with metastatic small cell lung cancer (SCLC) whose cancer has progressed after platinum-based chemotherapy and at...
Read Article
(Yale News) Aug 7, 2018 - Testing for dozens of genetic mutations in tumors of patients with a common form of advanced lung cancer did not appear to improve survival compared to routine genetic testing, a study led by Yale Cancer Center (YCC) scientists has found. The research was published in JAMA. Broad-based genomic sequencing...
Read Article
Latest Articles
August 16, 2018
August 16, 2018
August 13, 2018
August 13, 2018
August 10, 2018
August 09, 2018
August 09, 2018
August 08, 2018
View More
News Commentary
Editor Image
08 Aug, 2018 | by H. Jack West, MD
This doesn't mean that NGS testing is useless, but we must be careful not to...
View Comment
Editor Image
25 Jul, 2018 | by H. Jack West, MD
Nice to see, though not surprising. Brigatinib is a very good second generation...
View Comment
View More
OBR Blog
There are no Lung (includes NSCLC, SCLC, Mesothelioma) blog entries.